��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2003, 29(1) 10-13 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��
	��
	��м��
	��
	�ų��
	��
	PubMed
	Article by
	Article by

��м��о��һЩ��չ

�ų��, ��

ɽ��ʡƤ��Բ��о��, �� 250022

ժҪ��

��м��ͷ��Բ��ȷ,��ڹ�ȥ��20��,��м��ʶ�ս��.��Ŵ�ѧ��ѧ��Ƽ��Ѫ��ɺ��ӡ��л��Ʒ��Ԥ��Ʒ��ȽǶȶ��м��Ĳ��򡢷��ƺ��Ʒ��.�ڴ˻��,չ��δ��м��Ʒ��.

�ؼ���� м��

Abstract:

Keywords:

�ո�� 2002-03-05 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Andressen C,Henseler T.Inheritance of psoriasis.Analysis of 2035 family histories.Hautarzt,1982,33(4);214-217.
[2] Capon F,NovelliG,Semprini S,et al.Searching for psoriasis susceptibility genes in Italy:genome scan and evidence for a new locus on chromosome 1.J Invest Dermatol,1999,112(1);32-35.
[3] Cheng L,Zhang SZ,Xiao CY,et al.The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese.Br J Dermatol,2000,143(2);324-329.
[4] Schon MP.Animal models of psoriasis-what can we learn from them? J Invest Dermatol,1999,112(4);405-410.
[5] Roses AD.Pharmacogenetics and the practice of medicine.Nature,2000,405(6788);857-865.
[6] Magilavy D.Immunopharmacologic effects of Amevive(LFA3-TIP)in chronic plaque psoriasis:selectivity for peripheral memory effector(CD45 RO + over naive CD45 RA +)T cells.Br J Dermatol,1999,141:990(Abstr).
[7] Mrowietz U,Zhu K,Christophers E.Treatment of severe psoriasis with anti-CD25 monoclonal antibodies.Arch Dermatol,2000,136(5);675-676.
[8] Asadullah K,Sabat R,Wiese A,et al.Interleukin-10 in cutaneous disorders:implications for its pathophysiological importance and therapeutic use.Arch Dermatol Res,1999,291(12);628-636.
[9] Prinz JC,Vollmer S,Boehncke WH,et al.Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris.Eur J Immunol,1999,29(10):3360-3368.
[10] Menssen A,Trommler P,Vollmer S,et al.Evidence for an antigenspecific cellular immune response in skin lesions of patients with psoriasis vulgaris.J Immunol,1995,155(8);4078-4083.
[11] Zonneveld IM,Rubins A,Jablonska S,et al.Topical tacrolimus is not effective in chronic plaque psoriasis.A pilot study.Arch Dermatol,1998,134(9):1101-1102.
[12] Reitamo S,Spuls P,Sassolas B,et al.A double-blind study in patients with severe psoriasis to assess the clinical activity and safety of rapamycin(sirolimus)alone or in association with a reduced dose of cyclosporin,Br J Dermatol,1999,141:978-979(Abstr).
[13] Bhushan M,McLaughlin B,Weiss JB,et al.Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.Br J Dermatol,1999,141(6):1054-1060.
[14] Powell TJ,Ben-Bassat H,Klein BY,et al.Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors.Br J Dermatol,1999,141(5);802-810.
[15] Kuijpers AL,Van Pelt JP,Bergers M,et al.The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.Br J Dermatol,1998,139(3);380-389.
[16] Barna M,Bos JD,Kapsenberg ML,et al.Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis.Br J Dermatol,1997,136(4);536-541.
[17] Ellis CN,Varani J,Fisher GJ,et al.Troglitazone improves psoriasis and normalizes models of proliferative skin disease:ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.Arch Dermatol,2000,136(5);609-616.
[18] Kirby B,Richards HL,McElhone K,et al.Psychological distress affects the efficacy of PUVA in patients with psoriasis.Br J Dermatol,2000,143(Suppl 57):15-24.
[19] Pike JL,Smith TL,Hauger RL,et al.Chronic life stress alters sympathetic,neuroendocrine,and immune responsivity to an acute psychological stressor in humans.Psychosom Med,1997,59(4):447-457.
[20] Shackley DC,Whitehurst C,Clarke NW,et al.Photodynamic therapy..J R Soc Med,1999,92(11);562-565.
[21] Asawanonda P,Anderson RR,Chang Yet al.308-nm excimer laser for the treatment of psoriasis:a dose-response study.Arch Dermatol,2000,136(5);619-624.